Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004633181 | SCV005122328 | uncertain significance | Inborn genetic diseases | 2024-06-16 | criteria provided, single submitter | clinical testing | The c.1968C>G (p.N656K) alteration is located in exon 1 (coding exon 1) of the IRF2BPL gene. This alteration results from a C to G substitution at nucleotide position 1968, causing the asparagine (N) at amino acid position 656 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |